Beyond the Headlines

It used to be the B word that we moaned and groaned about.

It’s now become the C word.

BREXIT seems like an age ago. COVID will hopefully too, soon enough. Yet currently it is still a real and present danger – and we’re not out of the global pandemic woods just yet.

Fears of a second wave are also looming, as countries around the world begin to pick up the pieces from this devastating disease as they attempt to get back to some sort of “normality”.

You can now download a widget that will hide any mention of COVID related news when you are browsing the web or on social media. One can see the appeal of such a function though I’m not sure what sticking your head in the sand will achieve in the long term.

The headlines are pretty gloomy and it is difficult to put a positive spin on anything coming out in the news at the moment. Charities – just like everyone else – are severely being hampered by the pandemic. Fellow medical research charities in the UK are predicting anywhere between 25-40% or more drop in income as fundraising activities are being cancelled left right and centre.

It is crucial that we don’t stick our heads in the sand and hope that all this blows away – it’s not going to.

People with bowel cancer and bowel disease are no different from everyone else experiencing extreme difficulties in respects to their health and well being. The headlines are indeed devastating and the effect on patients and families is difficult to fathom at this point in time.

What we do know that it is imperative that we continue to support evidence-based research projects that will help us understand bowel cancer and bowel disease better – in order that we can continue to back projects that will help to develop clinical practice and ultimately improve the lives of patients.

Now more than ever we need the top scientists working collaboratively across the UK to help build and shape the research agenda to meet the needs of the new world that we face.

Together with our partners at Bowel & Cancer Research, we have already begun to play our part in tackling COVID-19 right at the epicentre of the pandemic by pumping funding into COVID SURG –  a rapid responsive research collaborative launched to support surgical policy & practice.

Our portfolio of research grants, PPI initiatives and PHD programmes that both charities currently fund are being severely affected and the headlines above are indeed forecasting worse to come.

We’re supporting the Association of Medical Research Charities campaign to urgently call for Government to commit to the proposed Life Sciences Charity Partner Fund. The purpose of which is :

  • To preserve the world-leading research capability that medical research charities have built in the UK that will ultimately provide benefits to patients, including the breadth of charity research across disease areas that includes rare and less common conditions;
  • To mitigate the risk of losing the capacity and skills built by the sector within universities and the NHS, setting back the quest for transformative outcomes for patients by a significant number of years;
  • To harness contributions from medical research charities towards a R&D-driven economic and social post-Covid-19 recovery;
  • To fulfil government ambitions to be a global science superpower by capitalising on the UK’s unique charity sector.

We’re also asking you  to see how you can help us in this time of desperate need. We understand that times are tough for all but we need your help now more than ever so that we can tackle this situation head-on and begin to build a research programme fit for the post-COVID age.

Will you answer our appeal for support and make a donation today?

Our beneficiaries – the hundreds of thousands of people who live with problems affecting their bowels throughout the UK – will be ever so grateful for your support.

Please do pass this message on and help us go beyond the headlines and bring some much needed good news to the table in the coming months and years for people with bowel cancer and bowel disease.